Metabolomic study of eyeball rupture and patients with cataracts in aqueous humor

Wei,Qingquan; Wei,Qingquan; Luo,Liyin; Luo,Liyin; Qiu,Wei; Qiu,Wei; Gong,Yingying; Gong,Yingying; Jiang,Yanyun; Jiang,Yanyun

doi:10.3892/etm.2022.11593

Metabolomic study of eyeball rupture and patients with cataracts in aqueous humor

Authors:
- Qingquan Wei
- Liyin Luo
- Wei Qiu
- Yingying Gong
- Yanyun Jiang
View Affiliations

Affiliations: Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
Published online on: September 7, 2022 https://doi.org/10.3892/etm.2022.11593
Article Number: 657
Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to identify metabolic biomarkers and study the metabolic changes in relation to cataracts and eyeball rupture in human aqueous humor. This case‑control study included 3 patients with traumatic ocular rupture treated by surgery as the control group, 10 patients with severe cataracts as the severe cataracts group and 10 patients with mild cataracts as the mild cataracts group. The present study used liquid chromatography‑mass spectrometry to analyze the metabolomics of aqueous humor samples. Databases including the Kyoto Encyclopedia of Genes and Genomes and MetaboAnalyst were used to find potential pathways for metabolites. Aqueous humor metabolic spectrum can competently distinguish patients with different degrees of cataracts from the control group. A total of 34 metabolites were identified as potential biomarkers that could distinguish patients with different degrees of cataracts; 36 metabolites were identified as potential biomarkers that could distinguish patients with severe cataracts from the control group; 34 metabolites were identified as potential biomarkers that could distinguish patients with mild cataracts from controls. In pathway analysis, glycerolphospholipid metabolism was highly affected, which meant that these metabolic markers serve an important role in the regulation of this pathway. The present study identified valuable metabolic biomarkers and pathways, which is helpful for an improved understanding of the pathogenesis of cataracts. This discovery has transformation value for the development of new treatment methods for cataracts.

View Figures

View References

1	Wang W, Yan W, Fotis K, Prasad NM, Lansingh VC, Taylor HR, Finger RP, Facciolo D and He M: Cataract surgical rate and socioeconomics: A global study. Invest Ophthalmol Vis Sci. 57:5872–5881. 2016.PubMed/NCBI View Article : Google Scholar
2	Liu YC, Wilkins M, Kim T, Malyugin B and Mehta JS: Cataract. Lancet. 390:600–612. 2017.PubMed/NCBI View Article : Google Scholar
3	Vinson JA: Oxidative stress in cataract. Pathophysiology. 13:151–162. 2006.PubMed/NCBI View Article : Google Scholar
4	Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C and Tardieu A: Ageing and vision: Structure, stability and function of lens crystallins. Prog Biophys Mol Biol. 86:407–485. 2004.PubMed/NCBI View Article : Google Scholar
5	Tsentalovich YP, Verkhovod TD, Yanshole VV, Kiryutin AS, Yanshole LV, Fursova AZ, Stepakov DA, Novoselov VP and Sagdeev RZ: Metabolomic composition of normal aged and cataractous human lenses. Exp Eye Res. 134:15–23. 2015.PubMed/NCBI View Article : Google Scholar
6	Williams DL: Oxidation, antioxidants and cataract formation: A literature review. Vet Ophthalmol. 9:292–298. 2006.PubMed/NCBI View Article : Google Scholar
7	Kim YM and Heyman HM: Mass spectrometry-based metabolomics. Methods Mol Biol. 1775:107–118. 2018.PubMed/NCBI View Article : Google Scholar
8	Zhao YY, Cheng XL, Vaziri ND, Liu S and Lin RC: UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clin Biochem. 47:16–26. 2014.PubMed/NCBI View Article : Google Scholar
9	Kell DB and Goodacre R: Metabolomics and systems pharmacology: Why and how to model the human metabolic network for drug discovery. Drug Discov Today. 19:171–182. 2014.PubMed/NCBI View Article : Google Scholar
10	Chen L, Cheng CY, Choi H, Ikram MK, Sabanayagam C, Tan GSW, Tian D, Zhang L, Venkatesan G, Tai ES, et al: Plasma metabonomic profiling of diabetic retinopathy. Diabetes. 65:1099–1108. 2016.PubMed/NCBI View Article : Google Scholar
11	Kliuchnikova AA, Samokhina NI, Ilina IY, Karpov DS, Pyatnitskiy MA, Kuznetsova KG, Toropygin IY, Kochergin SA, Alekseev IB, Zgoda VG, et al: Human aqueous humor proteome in cataract, glaucoma and pseudoexfoliation syndrome. Proteomics. 16:1938–1946. 2016.PubMed/NCBI View Article : Google Scholar
12	Taube AB, Hardenborg E, Wetterhall M, Artemenko K, Hanrieder J, Andersson M, Alm A and Bergquist J: Proteins in aqueous humor from cataract patients with and without pseudoexfoliation syndrome. Eur J Mass Spectrom (Chichester). 18:531–541. 2012.PubMed/NCBI View Article : Google Scholar
13	Barbas-Bernardos C, Armitage EG, Garcia A, Mérida S, Navea A, Bosch-Morell F and Barbas C: Looking into aqueous humor through metabolomics spectacles-exploring its metabolic characteristics in relation to myopia. J Pharm Biomed Anal. 127:18–25. 2016.PubMed/NCBI View Article : Google Scholar
14	Pietrowska K, Dmuchowska DA, Samczuk P, Kowalczyk T, Krasnicki P, Wojnar M, Skowronska A, Mariak Z, Kretowski A and Ciborowski M: LC-MS-based metabolic fingerprinting of aqueous humor. J Anal Methods Chem. 2017(6745932)2017.PubMed/NCBI View Article : Google Scholar
15	Tan SZ, Begley P, Mullard G, Hollywood KA and Bishop PN: Introduction to metabolomics and its applications in ophthalmology. Eye (Lond). 30:773–783. 2016.PubMed/NCBI View Article : Google Scholar
16	Ji Y, Rao J, Rong X, Lou S, Zheng Z and Lu Y: Metabolic characterization of human aqueous humor in relation to high myopia. Exp Eye Res. 159:147–155. 2017.PubMed/NCBI View Article : Google Scholar
17	Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D and Wu SY: The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol. 111:831–836. 1993.PubMed/NCBI View Article : Google Scholar
18	Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M and Tanabe M: Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res. 42:D199–D205. 2014.PubMed/NCBI View Article : Google Scholar
19	Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS and Xia J: MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46:W486–W494. 2018.PubMed/NCBI View Article : Google Scholar
20	Giblin FJ: Glutathione: A vital lens antioxidant. J Ocul Pharmacol Ther. 16:121–135. 2000.PubMed/NCBI View Article : Google Scholar
21	Gulluni F, Prever L, Li H, Krafcikova P, Corrado I, Lo WT, Margaria JP, Chen A, Santis MCD, Cnudde SJ, et al: PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation. Science. 374(eabk0410)2021.PubMed/NCBI View Article : Google Scholar
22	Yanshole VV, Yanshole LV, Snytnikova OA and Tsentalovich YP: Quantitative metabolomic analysis of changes in the lens and aqueous humor under development of age-related nuclear cataract. Metabolomics. 15(29)2019.PubMed/NCBI View Article : Google Scholar
23	Yu M, Jia HM, Cui FX, Yang Y, Zhao Y, Yang MH and Zou ZM: The effect of Chinese herbal medicine formula mKG on allergic asthma by regulating lung and plasma metabolic alternations. Int J Mol Sci. 18(602)2017.PubMed/NCBI View Article : Google Scholar
24	Wang S, Tang K, Lu Y, Tian Z, Huang Z, Wang M, Zhao J and Xie J: Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. Clin Chim Acta. 513:34–42. 2021.PubMed/NCBI View Article : Google Scholar
25	Yan F, Wen Z, Wang R, Luo W, Du Y, Wang W and Chen X: Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics. BMC Pulm Med. 17(174)2017.PubMed/NCBI View Article : Google Scholar
26	Zeng C, Wen B, Hou G, Lei L, Mei Z, Jia X, Chen X, Zhu W, Li J, Kuang Y, et al: Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. Gigascience. 6:1–11. 2017.PubMed/NCBI View Article : Google Scholar
27	Łuczaj W, Gęgotek A and Skrzydlewska E: Analytical approaches to assess metabolic changes in psoriasis. J Pharm Biomed Anal. 205(114359)2021.PubMed/NCBI View Article : Google Scholar